Search

Issue
Title
Authors
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N.V., Artamonova E.V., Beloyartseva M.F., Volkova E.I., Ganshina I.P., Troshina E.A., Tjulandin S.A., Chubenko V.A.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.V.
Opportunities for metastatic triple negative breast cancer therapy
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
The use of regorafenib in colorectal cancer
Sekacheva M.I., Bagmet N.N., Guryanova A.A., Rashi D.A.
Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy
Abdurakhmanov D.T., Breder V.V., Bolotina L.V., Kosyrev V.I., Medvedeva B.M., Petkau V.V.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
Orlova R.V., Zhukova L.G., Ganshina I.P., Yukalchuk D.Y., Ponomarenko D.M., Beliak N.P., Gordeeva O.O., Erdniev S.P., Minasyan A.A., Dashkova A.A., Sopiya E.R., Sholokhova E.A., Gurochkin A.B.
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal
Glebovskaya V.V., Tkachev S.I., Ivanov S.M., Nazarenko A.V., Rasulov A.O., Gordeev S.S., Bulychkin P.V., Besova N.S., Barsukov U.A., Trofimova O.P., Borisova T.N., Timoshkina E.V.
Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Demidova I.A.
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
Khokhlova S.V.
Concerning selective neck dissections in oral squamous cell carcinoma
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
Male breast cancer: review of the literature
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.S.
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A.A., Ivanov S.A.
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.V.
Surgical stading local – cervical cancer incidence
Kargopolova M.V., Maximov S.Y., Berlev I.V., Boyarkina M.P., Meshkova I.E., Khadzhimba A.S., Novikov S.N., Krzhivitsky P.I., Ponomareva O.I., Urmancheeva A.F., Ivanzov A.O., Guseynov K.D., Vishinskaya E.A., Matveeva N.S.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I.I., Abakumova T.V., Gening T.P., Gening S.O.
Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni
Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii
Ad\"yuvantnoe lechenie raka tolstoy kishki
Artamonova E.V., Podregul'skiy K.E.
Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Myasnikova M.O.
Mesto UZT pri planirovanii lecheniya zlokachestvennykh epitelial'nykh opukholey yaichnikov
Chekalova M.A., Poddubnaya I.V., Mazyrko M.A., Sinitsina M.E.
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh kozhi v Navoiyskoy oblasti Respubliki Uzbekistan
Kudryavtsev I.Y., Aksel' E.M., Kerimov R.A.
Endoskopicheskaya semiotika i diagnostika limfom glotochnogo kol'tsa Pirogova-Val'deyera
Belousova N.V., Poddubnyy B.K., Ungiadze G.V., Arkhipov V.V., Gubin A.N.
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga
Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B.
Prognostic significance of androgen receptor expression in triple-negative breast cancer
Panchenko I.S., Panchenko S.V., Sharafutdinov M.G., Rodionov V.V., Kometova V.V., Burmenskaya O.V.
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
Ognerubov N.A., Barsukov S.V.
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review
Grechukhina K.S., Kalugin M.V., Prosvirnov A.A., Sukhova M.V., Zhukova L.G.
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"
Ryazhenov V.V., Orlov S.V., Ivakhnenko O.I.
Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series
Lyadov V.K., Moskalenko A.N., Britskaia N.N.
Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
Zhabina A.S., Moiseenko F.V., Volkov N.M., Abduloeva N.K., Moiseenko V.M.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I.V., Gligorov J., Zhukova L.G., Kovalenko E.I., Frolova M.A.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I.B., Snegovoy A.V., Grebennikova O.P., Sel’chuk V.Y., Palchinskaia O.V.
Serous borderline ovarian tumors: modern possibilities of ultrasound diagnostics in monitoring the course of the disease after organ-preserving operations
Davydova I.I., Chekalova M.A., Karseladze A.I., Kuznetsov V.V., Meshcheriakova L.A., Dedy T.V., Cherkasov E.I., Zharova A.S.
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N.
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice
Sakaeva D.D., Ruchkin V.V., Goncharova O.V., Abbasova R.R., Mufazalov F.F.
Lung cancer in the Tomsk region (epidemiological aspects)
Choynzonov E.L., Zhuikova L.D., Ananina O.A., Odintsova I.N., Pikalova L.V.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
Ribociclib in 1st line HR+ breast cancer treatment
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
Kit O.I., Vladimirova L.Y., Abramova N.A., Storozhakova A.E., Popova I.L., Tikhanovskaya N.M., Lyaynova A.A., Ryadinskaya L.A.
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Surgical treatment and clinicopathological characteristics of patients with neuroendocrine neoplasms of the stomach
Bokhyan V.Y., Peregorodiev I.N., Delektorskaya V.V., Arkhiri P.P., Stilidi I.S.
Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
Latent herpes virus infection in the carcinogenesis of bladder cancer
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Kolbasov D.N., Kononkov I.V.
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
Clinical case long-term care of the patient with mCRPC
Zaborskiy I.N., Karjakin O.B.
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials)
Kolyadina I.V., Poddubnaya I.V.
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.V.
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka
Meshcheryakov A.A.
Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
Press-reliz Novaya era v lechenii raka pochki
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes)
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Rak zheludka: standarty i individual'nye aspekty taktiki khirurgicheskogo lecheniya
Khvastunov R.A., Danilov S.P.
Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan)
Kudryavtsev I.Y., Kerimov R.A.
Takticheskie podkhody k lecheniyu regionarnykh metastazov u bol'nykh rakom gortani, gortanoglotki, slizistoy obolochki polosti rta i rotoglotki
Aydarbekova A., Lyubaev V.L., Tkachev S.I., Alieva S.B., Brzhezovskiy Z.
Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
Letyagin V.P., Vysotskaya I.V.
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Semiglazov V.F., Poddubnaya I.V.
Blood management of patients with stage II–III colorectal cancer: Results of a comparative study
Lyadov V.K., Kornev D.O., Moskalenko A.N., Galkin V.N.
Current technologies of response assessment in rectal cancer after neoadjuvant treatment: A review
Orlov A.E., Kaganov O.I., Frolov S.A., Blinov N.V., Okulevich N.B.
Results of pelvic exenteration in patients with cervical cancer: clinical experience
Khakimov G.A., Khakimova G.G.
Remote multimodal prehabilitation in the presence of cachexia and resectable gastric cancer: a clinical case
Lyadov V.K., Boldyreva T.S., Achkasov E.E., Gorshkov A.Y., Chashchin M.G., Protsenko E.V., Starodubova V.V., Galkin V.N.
Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study
Volkova M.I., Kalpinskiy A.S., Menshikov K.V., Gorbuleva L.V., Sultanbaev A.V., Evsyukova O.I., Meltonian V.R., Mishugin S.V., Maturov M.R., Olshanskaya A.S., Shemetov D.I., Sannikova T.A., Makhnutina M.V., Filipieva M.A., Gaijsina E.A., Ovchinnikova E.G., Mailian O.A., Alekseev B.Y., Matveev V.B.
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases
Polyanskaya E.M., Fedyanin M.I.
Classification of breast cancer subtypes based on RNA profiling and immunohistochemical methods: clinical and biological aspects: A review
Imyanitov E.N.
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence
Editorial B.
Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021
Editorial B.
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Sitnikova V.A.
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis
Goryaynov S.V.
Prostate cancer
Kaprin A.D., Alekseev B.I., Matveev V.B., Pushkar’ D.I., Govorov A.V., Gorban’ N.A., Kirichek A.A., Biriukov V.A., Volkova M.I., Gulidov I.A., Gumenetskaia I.V., Krylov V.V., Kariakin O.B., Krasheninnikov A.A., Mardynskii I.S., Niushko K.M., Zakharova T.I., Kostin A.A., Khmelevskii E.V., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Isolated splenic metastases from colon cancer: clinical observations
Ognerubov N.A., Antipova T.S., Ognerubova M.A.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
Vulvar cancer: brain metastases. Clinical observation
Ognerubov N.A., Antipova T.S., Kamneva N.A.
Differentiated thyroid cancer
Bel’tsevich D.G., Mudunov A.M., Vanushko V.E., Rumiantsev P.O., Mel’nichenko G.A., Kuznetsov N.S., Podvyaznikov S.O., Alymov Y.V., Poliakov A.P., Fadeev V.V., Bolotin M.V., Sevriukov F.E., Krylov V.V., Fedenko A.A., Bolotina L.V., Zharov A.A., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A.S., Fedyanin M.Y., Pokataev I.A., Tyulyandin S.A.
Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case
Gorbunova T.V., Radtsig E.I., Merkulov O.A., Bogomil’skii M.R., Poliakov V.G.
Differential diagnosis of lung cancer and tuberculosis: review
Belova O.S., Komarov I.G.
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients
Artamonova E.V., Kovalenko E.I., Snegovoy A.V., Aksarin A.A., Anciferova T.A., Belonogov A.V., Bilan E.V., Bilenko S.N., Varvus I.M., Gorkovenko E.A., Enikeev R.F., Ermolaeva A.M., Kramskaya L.V., Kononenko I.B., Pechenyy A.P., Safina S.Z., Chupriyanova T.V., Chuhua G.G., Shemyakina A.I., Shikina E.V.
Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.V.
The results of the treatment of patients with advanced hepatocellular carcinoma in Sverdlovsk region
Petkau V.V., Tarkhanov A.A., Kiselev E.A.
Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Artamonova E.V.
Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K.
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
Frolova M.A.
Rare morphological forms of breast cancer: features of surgical approach
Vysotskaya I.V., Letyagin V.P., Kolyadina I.V., Martynova G.V.
Neoadjuvant systemic therapy of HER2-positive breast cancer
Frolova M.A.
Intrahepatic cholangiocellular carcinoma (review)
Zharikov Y.O., Shevchenko T.V., Zhao A.V.
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A.V., Gorbacheva A.V.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.S.
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Ahmetzanov F.S., Ahmetzanova F.F.
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I.V., Bichurina S.A., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Petrukhnenko V.A., Sivunova I.D., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR
Bolotina L.V.
Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye)
Artamonova E.V.
Combined and complex treatment options for patients with operable rectal cancer
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo
Poddubnaya I.V.
Kombinirovannoe lechenie metastazov kolorektal'nogo raka v pechen' s primeneniem regionarnoy khimioterapii
Kotiv B.N., Alent'ev S.A., Dzidzava I.I.
Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
Borisova E.I., Voronina I.Y., Gutorov S.L.
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake
Voznyy E.K., Popov A.Y., Astrakhankina T.A., Grishunenkova E.P., Polyanskaya E.V.
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
Khvastunov R.A., Kireev A.V., Nikol'skiy I.V., Suvorov V.A.
Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let?
Bychkov M.B.
Pemetreksed (alimta)
Tyulyandin S.A.
Sravnitel'naya kharakteristika taksanosoderzhashchikh i platinovykh skhem polikhimioterapii v pervoy linii lecheniya raka yaichnikov IV stadii (opyt GVKB im. N.N.Burdenko)
Mel'ko A.I., Ushakov I.I., Kira E.F., Ermolinskiy I.I.
Znachimost' khromoskopii, endosonografii i uvelichitel'noy endoskopii v reshenii diagnosticheskikh problem predopukholevoy patologii i rannego raka zheludochno-kishechnogo trakta
Poddubnyy B.K., Kuvshinov Y.P., Malikhova O.A., Frolova I.P.
Opyt primeneniya Regional'noy programmy v g. Krasnodare
Mitashok I.S.
Which chemotherapy treatments are best for helping people with advanced pancreatic cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Kinaly I.
The first case of penile metastases of adrenocortical cancer: A clinical case
Ognerubov N.A., Antipova T.S.
Immunological predictors of the therapeutic efficacy of atezolizumab in combination with nab-paclitaxel in metastatic triple-negative breast cancer: A pilot multicenter retrospective associative study
Kalinchuk A.Y., Popova N.O., Gofman A.A., Usoltseva I.S., Perelmuter V.M., Tashireva L.A.
Comparison of efficacy and safety of regorafenib and anti-EGFR targeted therapy in metastatic colorectal cancer: A retrospective study
Kuzmina E.S., Fedyanin M.Y., Lyadova M.A., Fedorinov D.S., Polyanskiy M.A., Parts S.A., Pokataev I.A., Galkin V.N.
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
Savchenko I.V., Stilidi I.S., Dzhanyan I.A., Antonova E.Y., Polyakov A.N., Egorova A.V., Chulkova S.V., Breder V.V.
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study
Sultanbaev A.V., Kolyadina I.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Sultanbaeva N.I., Rakhimov R.R., Lipatov D.O., Menshikova I.A., Izmailov A.A., Lipatova E.E.
How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review
Zhukova L.G., Bordin D.S., Dubtsova E.A., Ilin M.A., Kiriukova M.A., Feoktistova P.S., Egorov V.I.
Relationship of the integrin profile of the primary tumor to metastasis to regional lymph nodes in breast cancer
Zavyalova M.V., Kuznecov G.A., Grigoryeva E.S., Tashireva L.A., Pismenny D.S., Perelmuter V.M.
Opportunities of ICG-fluorescent imaging of lymph nodes during radical cystectomy in patients with bladder cancer: A review
Pavlov V.N., Urmantsev M.F., Bakeev M.R.
Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study
Chulkova S.V., Sholokhova E.N., Poddubnaya I.V., Stilidi I.S., Burov D.A., Tupitsyn N.N.
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis
Valiachmetova C.K., Siraev E.R., Izmailov A.A.
The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study
Chulkova S.V., Sholokhova E.N., Poddubnaya I.V., Stilidi I.S., Tupitsyn N.N.
Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review
Nevolskikh A.A., Avdeenko V.A., Belokhvostova A.S., Mikhaleva Y.Y., Pochuev T.P., Zibirov R.F., Ivanov S.A., Kaprin A.D.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A.A., Fedyanin M.Y., Moiseenko F.V., Mironov O.V., Stroyakovskiy D.L., Sokolov N.I., Orlova S.A., Mantsyrev E.O., Sultanbaev A.V., Teterich A.A., Babina K.G., Yukalchuk D.Y., Borzyanitsa S.M., Isyangulova A.Z., Saidullaeva A.F., Chernova Y.A., Bobrova E.A., Fadeeva N.V., Chobanu D.Y.
The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial
Pushkarev E.A., Vazhenin A.V., Kulaev K.I., Iusupov I.M., Zuikov K.S., Popova I.A.
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E.V., Laktionov K.K.
Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
Brish N.A., Semiglazova T.Y., Karachun A.M., Shevkunov L.N., Ulyanchenko Y.A., Artemyeva A.S., Golovanova T.S., Tkachenko E.V., Alexeeva Y.V., Sharashenidze S.M., Strakh L.V., Protsenko S.A., Teletaeva G.M., Filatova L.V., Kasparov B.S., Semiglazov V.V., Belyaev A.M.
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K.V., Sultanbaev A.V., Akhmetgareeva K.T., Lipatov D.O.
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
Sokolova T.N., Aleksakhina S.N., Yanus G.A., Sultanbaev A.V., Menshikov K.V., Lysenko A.N., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Rossokha E.I., Bakharev S.Y., Basova E.A., Kasmynina T.A., Shumskaya I.S., Bakshun Y.I., Musaeva K.S., Khasanova A.I., Dmitriev V.N., Bolieva M.B., Gadzaova C.H., Petrenko O.L., Maksimov D.A., Vladimirov V.I., Goldberg V.E., Popova N.O., Kibisheva M.V., Khamgokov Z.M., Vasilyev A.E., Iyevleva A.G., Imyanitov E.N.
Cancer of an ectopic parathyroid gland: from diagnosis to treatment (clinical case)
Allakhverdiev A.K., Malkina N.A., Noskova K.K., Grinevich V.N., Feidorov I.Y., Ketsba A.F., Bystrovskay E.V., Embutniex Y.V., Putova M.V., Synkova D.A.
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer
Tabakov D.V., Zabotina T.N., Chanturia N.V., Zakharova E.N., Vorotnikov I.K., Selchuk V.Y., Sokolovskiy V.V., Petrovsky A.V.
Use of nivolumab for colon cancer with Lynch syndrome
Khakimov G.A., Tryakin A.A., Khakimova G.G.
Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
Statsenko G.B., Kurakin V.I., Plokhotenko I.V.
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
151 - 300 of 484 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».